Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Wort

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
British Journal of Anaesthesia|May 14, 2022
Use of sildenafil in patients with severe COVID-19 pneumonitisCharles McFadyen, Ben Garfield, Jennifer Mancio, et al.
Pulmonary Circulation|August 20, 2025
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary DiseaseSteven D Nathan, Lucilla Piccari, Steven H Abman, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 1, 2014
Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapiesGregory John Keir, Simon L F Walsh, Michael A Gatzoulis, et al.
Pulmonary Circulation|December 19, 2024
The hepcidin-ferroportin axis influences mitochondrial function, proliferation, and migration in pulmonary artery endothelial and smooth muscle cellsTheo Issitt, Quezia K Toe, Sofia L Pedersen, et al.
The European Respiratory Journal|April 17, 2021
A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression?Carmel Bergbaum, Chinthaka B Samaranayake, Alex Pitcher, et al.
Chest|January 22, 2022
Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on SurvivalMax Schwiening, Emilia M Swietlik, Divya Pandya, et al.
Respirology (Carlton, Vic.)|January 13, 2018
Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterizationGregory J Keir, S John Wort, Maria Kokosi, et al.
Journal of the American Heart Association|December 20, 2021
Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United KingdomAndrew Constantine, Konstantinos Dimopoulos, Petra Jenkins, et al.
ERJ Open Research|May 13, 2026
Assessment of noninvasive parameters prior to diagnosis of pulmonary hypertension in patients with fibrotic interstitial lung diseaseSophie Herbert, Konstantinos Dimopoulos, Ifan Jenkin, et al.
Respiration; International Review of Thoracic Diseases|April 24, 2022
The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung DiseaseLucilla Piccari, Stephen John Wort, Federica Meloni, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
British Journal of Anaesthesia|May 14, 2022
Use of sildenafil in patients with severe COVID-19 pneumonitisCharles McFadyen, Ben Garfield, Jennifer Mancio, et al.
Pulmonary Circulation|August 20, 2025
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary DiseaseSteven D Nathan, Lucilla Piccari, Steven H Abman, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|August 1, 2014
Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapiesGregory John Keir, Simon L F Walsh, Michael A Gatzoulis, et al.
Pulmonary Circulation|December 19, 2024
The hepcidin-ferroportin axis influences mitochondrial function, proliferation, and migration in pulmonary artery endothelial and smooth muscle cellsTheo Issitt, Quezia K Toe, Sofia L Pedersen, et al.
The European Respiratory Journal|April 17, 2021
A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression?Carmel Bergbaum, Chinthaka B Samaranayake, Alex Pitcher, et al.
Chest|January 22, 2022
Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on SurvivalMax Schwiening, Emilia M Swietlik, Divya Pandya, et al.
Respirology (Carlton, Vic.)|January 13, 2018
Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterizationGregory J Keir, S John Wort, Maria Kokosi, et al.
Journal of the American Heart Association|December 20, 2021
Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United KingdomAndrew Constantine, Konstantinos Dimopoulos, Petra Jenkins, et al.
ERJ Open Research|May 13, 2026
Assessment of noninvasive parameters prior to diagnosis of pulmonary hypertension in patients with fibrotic interstitial lung diseaseSophie Herbert, Konstantinos Dimopoulos, Ifan Jenkin, et al.
Respiration; International Review of Thoracic Diseases|April 24, 2022
The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung DiseaseLucilla Piccari, Stephen John Wort, Federica Meloni, et al.
Pageof 9